0001209191-23-026758.txt : 20230502
0001209191-23-026758.hdr.sgml : 20230502
20230502193427
ACCESSION NUMBER: 0001209191-23-026758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Witz Pascale
CENTRAL INDEX KEY: 0001703723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 23881182
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-28
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001703723
Witz Pascale
C/O HORIZON THERAPEUTICS PLC,
70 ST. STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
1
0
0
0
0
Ordinary Shares
2023-04-28
4
M
0
3913
A
18202
D
Ordinary Shares
2023-04-28
4
F
0
1879
111.16
D
16323
D
Ordinary Shares
29628
I
By Trust
Restricted Stock Units
2023-04-28
4
M
0
3913
0.00
D
2023-04-28
2023-04-28
Ordinary Shares
3913
0
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
14,289 Ordinary Shares previously reported as indirectly held by Trust held directly.
/s/ Meghanne Downes, Attorney-in-Fact
2023-05-02